GL1X · GenesisL1 explorer

Research workbench

AlphaFold monomer V2.0 prediction for tryptophan 2,3-dioxygenase (P21643)

Analyse AlphaFold monomer V2.0 prediction for tryptophan 2,3-dioxygenase (P21643) in the GL1X research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides, crosslinks and neighbours on the 3D structure.

Accession
P21643
Type
protein
Length
406 residues
Chains
1
Collection
MolNFT v1 / AlphaFold
Contract
0xBf7491af3407816DFa88a5EA4c82e8A2B1D721eD
Owner
0xB44F19a0cb161828322eEEd13F55d4C3C34938d2
Molecule
Tryptophan 2,3-dioxygenase
UniProt
P21643
Pockets
5 · best druggability 0.80

Structure

1 distinct chain · 64% helix, 0% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
ATryptophan 2,3-dioxygenaseprotein40664% helix, 0% strandP21643

Pockets

5 pockets found on a 1 Å grid, 3 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
15120.800.8646empty
21020.570.8514empty
3650.510.8616empty
4510.280.7517empty
5570.260.7311empty

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.